HQY

HQY

USD

HealthEquity Inc. Common Stock

$103.250-1.260 (-1.206%)

Reaalajas hind

Healthcare
Health Information Services
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$104.510

Kõrge

$104.560

Madal

$103.250

Maht

0.85M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

8.9B

Tööstusharu

Health Information Services

Riik

United States

Kauplemisstatistika

Keskmine maht

1.26M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $65.01Praegune $103.250Kõrge $116.65

Seotud uudised

Analyst Upgrades

Barrington Research Maintains Outperform on HealthEquity, Raises Price Target to $125

Barrington Research analyst Alexander Paris maintains HealthEquity with a Outperform and raises the price target from $112 to $125.

Vaata rohkem
Barrington Research Maintains Outperform on HealthEquity, Raises Price Target to $125
Analyst Upgrades

Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $115

Deutsche Bank analyst George Hill maintains HealthEquity with a Buy and raises the price target from $98 to $115.

Vaata rohkem
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $115
Analyst Upgrades

Goldman Sachs Maintains Neutral on HealthEquity, Raises Price Target to $104

Goldman Sachs analyst David Roman maintains HealthEquity with a Neutral and raises the price target from $94 to $104.

Vaata rohkem
Goldman Sachs Maintains Neutral on HealthEquity, Raises Price Target to $104
Analyst Upgrades

RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $117

RBC Capital analyst Daniel Perlin maintains HealthEquity with a Outperform and raises the price target from $112 to $117.

Vaata rohkem
RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $117
Analyst Upgrades

B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $125

B of A Securities analyst Allen Lutz maintains HealthEquity with a Buy and raises the price target from $110 to $125.

Vaata rohkem
B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $125
Analyst Upgrades

JMP Securities Maintains Market Outperform on HealthEquity, Raises Price Target to $117

JMP Securities analyst Constantine Davides maintains HealthEquity with a Market Outperform and raises the price target from $110 to $117.

GlobeNewswire

HealthEquity Reports First Quarter Ended April 30, 2025 Financial Results

Highlights of the first quarter include: Revenue of $330.8 million, an increase of 15% compared to $287.6 million in Q1 FY25.Net income of $53.9 million, an increase of 87% compared to $28.8 million in Q1 FY25, with